{"name": "Merrimack Pharmaceuticals",
 "permalink": "merrimack-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/merrimack-pharmaceuticals",
 "homepage_url": "http://www.merrimackpharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@merrimackpharma.com",
 "phone_number": "617-441-1000",
 "description": "",
 "created_at": "Wed Nov 10 07:06:03 UTC 2010",
 "updated_at": "Mon Apr 22 13:11:37 UTC 2013",
 "overview": "\u003Cp\u003EMerrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       27],
      "assets/images/resized/0010/9546/109546v1-max-150x150.png"],
     [[250,
       45],
      "assets/images/resized/0010/9546/109546v1-max-250x250.png"],
     [[284,
       52],
      "assets/images/resized/0010/9546/109546v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Robert",
      "last_name": "J. Mulroy",
      "permalink": "robert-j-mulroy",
      "image": null}},
   {"is_past": false,
    "title": "Chairman",
    "person":
     {"first_name": "Gary",
      "last_name": "Crocker",
      "permalink": "gary-crocker",
      "image":
       {"available_sizes":
         [[[90,
            108],
           "assets/images/resized/0026/7878/267878v1-max-150x150.jpg"],
          [[90,
            108],
           "assets/images/resized/0026/7878/267878v1-max-250x250.jpg"],
          [[90,
            108],
           "assets/images/resized/0026/7878/267878v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "",
    "person":
     {"first_name": "Anthony",
      "last_name": "J. Sinskey",
      "permalink": "anthony-j-sinskey",
      "image":
       {"available_sizes":
         [[[140,
            140],
           "assets/images/resized/0027/5965/275965v1-max-150x150.png"],
          [[140,
            140],
           "assets/images/resized/0027/5965/275965v1-max-250x250.png"],
          [[140,
            140],
           "assets/images/resized/0027/5965/275965v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Member, Scientific Advisory Board",
    "person":
     {"first_name": "K.",
      "last_name": "Dane Wittrup",
      "permalink": "k-dane-wittrup",
      "image":
       {"available_sizes":
         [[[124,
            124],
           "assets/images/resized/0027/1389/271389v1-max-150x150.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1389/271389v1-max-250x250.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1389/271389v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$79.4M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://www.merrimackpharma.com/newsEvents/2010/TDP%20Award%20Release%20FINAL%2008Nov10.pdf",
    "source_description": "Merrimack Pharmaceuticals Awarded $2.44 Million in Grants Under the Patient Protection and Affordable Care Program",
    "raised_amount": 2440000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 8,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/merrimack-raises-77m-cancer-work/2011-04-14?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Merrimack raises $77M for cancer work",
    "raised_amount": 77000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 4,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Crocker Ventures",
         "permalink": "crocker-ventures",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0018/3288/183288v1-max-150x150.jpg"],
             [[250,
               46],
              "assets/images/resized/0018/3288/183288v1-max-250x250.jpg"],
             [[280,
               52],
              "assets/images/resized/0018/3288/183288v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Jennison Associates",
         "permalink": "jennison-associates",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0008/4571/84571v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0008/4571/84571v1-max-250x250.jpg"],
             [[393,
               55],
              "assets/images/resized/0008/4571/84571v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TPG-Axon Capital",
         "permalink": "tpg-axon-capital",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "WT Investmen",
         "permalink": "wt-investmen",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "WT Investment Advisors Fund",
         "permalink": "wt-investment-advisors-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Credit Suisse First Boston Next Fund",
         "permalink": "credit-suisse-first-boston-next-fund",
         "image": null},
       "person": null}]},
   {"round_code": "b",
    "source_url": "",
    "source_description": "",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2002,
    "funded_month": 1,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Expansion Venture Capital",
         "permalink": "expansion-venture-capital",
         "image":
          {"available_sizes":
            [[[70,
               69],
              "assets/images/resized/0019/8388/198388v2-max-150x150.png"],
             [[70,
               69],
              "assets/images/resized/0019/8388/198388v2-max-250x250.png"],
             [[70,
               69],
              "assets/images/resized/0019/8388/198388v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Kendall Square",
    "address2": "Suite B7201",
    "zip_code": "02139",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Merrimack Pharma pays $220M for Taiwanese drug firm",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 9,
    "source_url": "http://www.masshightech.com/stories/2011/05/09/daily5-Merrimack-Pharma-pays-220M-for-Taiwanese-drug-firm.html",
    "source_text": "",
    "source_description": "Merrimack Pharma pays $220M for Taiwanese drug firm",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Merrimack Pharmaceuticals",
      "permalink": "merrimack-pharmaceuticals"}},
   {"description": "will pay Taiwanese drug maker PharmaEngine up to $220 million in up-front and milestone payments in return for the Asian and European rights to develop, manufacture and commercialize a potential treatment for pancreatic and gastric cancers",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 9,
    "source_url": "http://www.masshightech.com/stories/2011/05/09/daily5-Merrimack-Pharma-pays-220M-for-Taiwanese-drug-firm.html",
    "source_text": null,
    "source_description": "Merrimack Pharma pays $220M for Taiwanese drug firm",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Merrimack Pharmaceuticals",
      "permalink": "merrimack-pharmaceuticals"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2012,
   "pub_month": 3,
   "pub_day": 29,
   "stock_symbol": "NASDAQ:MACK"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}